Other studies have reported that the combination of a SIRT1 inhibitor with anti-CRC drugs such as 5-FU, SN-38, or oxaliplatin can promote cell apoptosis and enhance the anti-tumor effect (Ueno et al., 2013). Here, SIRT1 is linked to colorectal carcinoma.